Minipress

In the US, Minipress (prazosin systemic) is a member of the drug class antiadrenergic agents, peripherally acting and is used to treat Anxiety and Stress, Benign Prostatic Hyperplasia, Heart Failure, High Blood Pressure, Post Traumatic Stress Disorder and Raynaud's Syndrome.

US matches:

• Minipress

Ingredient matches for Minipress

Prazosin

Prazosin is reported as an ingredient of Minipress in the following countries:

• Sri Lanka

Prazosin hydrochloride (a derivative of Prazosin) is reported as an ingredient of Minipress in the following countries:

• Australia


• Bahrain


• Belgium


• Brazil


• Egypt


• Ethiopia


• France


• Ghana


• Guyana


• Hong Kong


• Hungary


• India


• Japan


• Jordan


• Kenya


• Kuwait


• Lebanon


• Liberia


• Luxembourg


• Malawi


• Nigeria


• Oman


• Philippines


• Romania


• Saudi Arabia


• Sierra Leone


• Singapore


• Sudan


• Taiwan


• Thailand


• United Arab Emirates


• United States

International Drug Name Search